Future studies will further test the hypothesis that the observed CAF and immune response in the TME is the underlying mechanism of distinct responses to the combination of anti-IL-1β and anti-PD-1 in the primary tumor versus metastasis and different changes in the metastasis rate to the liver versus to the lung. Here, IL1B is linked to neoplasm.